Skip to Main Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

  1. Home
  2. PLCO
  3. Approved Projects

Approved PLCO Projects

Here you can browse the complete list of projects for PLCO whose requests for data/biospecimens were approved.

Data-Only Studies
Biospecimen Studies
Reset

Results: 1030 (Showing 1021 to 1030) — Export these results

Name Principal Investigator Institution Study Date Approved Project ID
Evaluating Screening Bias in Risk Factor Studies of Lung Cancer Nested in the PLCO Trial Timothy Church University of Minnesota PLCO Mar 31, 2006 2006-0307
Iron homeostasis and colorectal adenoma risk in the Prostate, Lung, Colorectal & Ovarian (PLCO) Cancer Screening Trial Amanda Cross NCI, DCEG, NEB PLCO Oct 24, 2005 2005-0012
Cell Cycle Variants and Metastatic Prostate Cancer Risk Adam Kibel Washington University PLCO Sep 23, 2005 2005-0001
C-GEMS: Cancer Genetic Markers of Susceptibility A Strategic Initiative to Identify Novel Genetic Determinants of Cancer Mitchell Machiela NCI, DCEG, LGS PLCO Aug 17, 2005 2005-0003
Breast Cancer: Molecular Epidemiology in the PLCO EEMS Cohort- Nutritional Factors Regina Ziegler NCI, DCEG, EBP PLCO Aug 17, 2005 2005-0010
Chromosomal aberrations in cultured peripheral blood lymphocytes and subsequent risk of leukemia and lymphoma Nathaniel Rothman - PLCO Aug 17, 2005 2005-0002
Telomere length, mitochondrial DNA mass, and risk for major chronic diseases Richard Hayes New York University PLCO Aug 17, 2005 2005-0006
Multiplexed Assay of Serum Biomarkers for Pancreatic Cancer Anna Lokshin University of Pittsburgh PLCO Aug 17, 2005 2005-0008
Inflammation regulation: Gene variants and inflammatory markers in colorectal neoplasia Sonja Berndt NCI, DCEG, OEEB PLCO Aug 17, 2005 2005-0011
Phase III validation using PLCO specimens of a consensus panel of ovarian cancer biomarkers developed by SPORE/EDRN investigators Daniel W. Cramer Brigham and Women's Hospital / Harvard Medical School PLCO Aug 17, 2005 2005-0009